Literature DB >> 10603394

Murine immune response to Neisseria meningitidis group C capsular polysaccharide: analysis of monoclonal antibodies generated in response to a thymus-independent antigen and a thymus-dependent toxoid conjugate vaccine.

P A García-Ojeda1, M E Monser, L J Rubinstein, H J Jennings, K E Stein.   

Abstract

Antibody (Ab) responses to polysaccharides (PSs) such as Neisseria meningitidis group C PS (MCPS) are characterized as being thymus independent (TI) and are restricted with regard to clonotype and isotype expression. PS conjugated to proteins, e.g., MCPS coupled to tetanus toxoid (MCPS-TT), elicits a thymus-dependent (TD) response. In order to understand the influence of the form of a vaccine (TI versus TD) on the Ab repertoire, we generated monoclonal antibody (MAb) panels from mice immunized and boosted with MCPS or MCPS-TT in different ways. The panels of MAbs were examined for isotype, fine specificity, affinity, and V(H) gene family usage. The use of MCPS-TT resulted in a shift in the isotype from immunoglobulin M (IgM) and IgG3 elicited in response to the MCPS to primarily IgG1. This isotype shift was accompanied by a change in the fine specificity of the response to the conjugate compared to that of PS. New fine specificities and increased affinity were observed in response to the TD antigen (Ag). Dot blot and Northern analyses of MCPS MAbs revealed that V(H) gene family usage is dominated by V(H)J558, used by 23 of 39 MAbs. V(H)3609 was seen in three MAbs of restricted fine specificity. V(H)Q52, V(H)7183, and V(H)VGAM3-8 were seen in more than one MAb across these panels, while V(H)10 and V(H)X24 were detected only once in response to the TI-2 Ag. All MAbs in the panels utilized kappa light chains, and all functional J(kappa) genes were expressed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10603394      PMCID: PMC97127          DOI: 10.1128/IAI.68.1.239-246.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  66 in total

1.  Impact of vaccines universally recommended for children--United States, 1990-1998.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1999-04-02       Impact factor: 17.586

2.  Strain-dependent restricted VH and VL usage by anti-bacterial levan monoclonal antibodies.

Authors:  C M Boswell; D C Irwin; J Goodnight; K E Stein
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

3.  Developmentally controlled expression of immunoglobulin VH genes.

Authors:  R M Perlmutter; J F Kearney; S P Chang; L E Hood
Journal:  Science       Date:  1985-03-29       Impact factor: 47.728

4.  Safety and immunogenicity of a Haemophilus influenzae type b conjugate vaccine in a high risk American Indian population.

Authors:  M Santosham; J Hill; M Wolff; R Reid; L Lukacs; V Ahonkhai
Journal:  Pediatr Infect Dis J       Date:  1991-02       Impact factor: 2.129

5.  A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants.

Authors:  P A Twumasi; S Kumah; A Leach; T J O'Dempsey; S J Ceesay; J Todd; C V Broome; G M Carlone; L B Pais; P K Holder
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

6.  Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization.

Authors:  S J Ceesay; S J Allen; A Menon; J E Todd; K Cham; G M Carlone; S H Turner; L L Gheesling; W DeWitt; B D Plikaytis
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

7.  The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.

Authors:  M Santosham; M Wolff; R Reid; M Hohenboken; M Bateman; J Goepp; M Cortese; D Sack; J Hill; W Newcomer
Journal:  N Engl J Med       Date:  1991-06-20       Impact factor: 91.245

8.  Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era.

Authors:  W G Adams; K A Deaver; S L Cochi; B D Plikaytis; E R Zell; C V Broome; J D Wenger
Journal:  JAMA       Date:  1993-01-13       Impact factor: 56.272

9.  Murine immune response to the Neisseria meningitidis group C capsular polysaccharide. II. Specificity.

Authors:  L J Rubinstein; K E Stein
Journal:  J Immunol       Date:  1988-12-15       Impact factor: 5.422

10.  Variable region sequences of murine IgM anti-IgG monoclonal autoantibodies (rheumatoid factors). A structural explanation for the high frequency of IgM anti-IgG B cells.

Authors:  M J Shlomchik; D A Nemazee; V L Sato; J Van Snick; D A Carson; M G Weigert
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

View more
  11 in total

1.  Pneumococcal capsular polysaccharide vaccine-mediated protection against serotype 3 Streptococcus pneumoniae in immunodeficient mice.

Authors:  Haijun Tian; Avi Groner; Marianne Boes; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

2.  A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice.

Authors:  Ulrike K Buchwald; Andrew Lees; Michael Steinitz; Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Avidity of the immunoglobulin G response to a Neisseria meningitidis group C polysaccharide conjugate vaccine as measured by inhibition and chaotropic enzyme-linked immunosorbent assays.

Authors:  Shannon L Harris; How Tsao; Lindsey Ashton; David Goldblatt; Philip Fernsten
Journal:  Clin Vaccine Immunol       Date:  2007-02-07

4.  Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains.

Authors:  Gregory R Moe; Patricia Zuno-Mitchell; Samantha N Hammond; Dan M Granoff
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

5.  Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870.

Authors:  Victor C Hou; Oliver Koeberling; Jo Anne Welsch; Dan M Granoff
Journal:  J Infect Dis       Date:  2005-07-15       Impact factor: 5.226

6.  Age-related disparity in functional activities of human group C serum anticapsular antibodies elicited by meningococcal polysaccharide vaccine.

Authors:  Shannon L Harris; W James King; Wendy Ferris; Dan M Granoff
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

7.  The Combining Sites of Anti-lipid A Antibodies Reveal a Widely Utilized Motif Specific for Negatively Charged Groups.

Authors:  Omid Haji-Ghassemi; Sven Müller-Loennies; Teresa Rodriguez; Lore Brade; Hans-Dieter Grimmecke; Helmut Brade; Stephen V Evans
Journal:  J Biol Chem       Date:  2016-03-01       Impact factor: 5.157

8.  Surface plasmon resonance analysis of antipolysaccharide antibody specificity: responses to meningococcal group C conjugate vaccines and bacteria.

Authors:  Pablo A García-Ojeda; Sharon Hardy; Steven Kozlowski; Kathryn E Stein; Ian M Feavers
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

9.  Chemoenzymatic synthesis of immunogenic meningococcal group C polysialic acid-tetanus Hc fragment glycoconjugates.

Authors:  Pumtiwitt C McCarthy; Rina Saksena; Dwight C Peterson; Che-Hung Lee; Yanming An; John F Cipollo; Willie F Vann
Journal:  Glycoconj J       Date:  2013-08-16       Impact factor: 2.916

10.  Purification of an IgA Monoclonal Antibody Specific for the Acr Protein of Mycobacterium tuberculosis by Immunoaffinity Chromatography.

Authors:  Fátima Reyes; Oscar Otero; Frank Camacho; María Elena Sarmiento; Armando Acosta
Journal:  Malays J Med Sci       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.